Havn

Private Company

Company Overview

Havn is a biotechnology company aimed at improving cognitive performance through the standardized extraction of psychoactive compounds and the development of natural health care products from novel compounds. 

With a research lab and offices located in the South Research Campus of The University of British Columbia and a team of scientists with extensive experience in chemistry and formulation development, the company is dedicated to helping people operate at peak mental performance and experience a considerable reduction in symptoms associated with mental illness.

Management Team


Susan Chapelle
Co-CEO

Tim Moore
Co-CEO

Dr. Ivan Casselman
Chief Psychedelics Officer

Alexzander Samuelsson
Chief Research Officer

Eli Dusenbury
CFO

Barinder Rasode
Executive Co-Chair

Robert Nygren
Executive Co-Chair

Sign Up for Alerts

Receive an email alert every time a company announces a merger, capital raise or files for an IPO.